The in vivo studies confirmed the pathogenic effects of DLBCL-derived Evs, as seen in the promotion of tumor growth and invasiveness, as well as the role of specific EV cargoes, such as CA1, miR-125b-5p, miR-107, and NSE, in tumor progression and chemoresistance. This evidence concerns the gene ENO2 and neoplasm.